GCB-DLBCL is characterized by persistent somatic hypermutation, BCL6 up-regulation, and almost universal CD10 expression, while ABC-DLBCL is associated with chronic activated B cell receptor signaling and NF-κB dysregulation (10). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.